Long-Acting Injectable: An Exciting New Option for HIV Prevention
Alex Rinehart, PhD, explains how the development of a long-acting injectable offers a new preventive option for HIV.
Alex Rinehart, PhD, Director, Global Prevention Strategy, ViiV Healthcare, explains how the development of a long-acting injectable could potentially offer a new preventive option for individuals at risk for HIV.
Related Videos
View All
Related Content
Looking to Safeguard Blood Supply, FDA Proposes Risk Assessment for Blood Donations
January 27th 2023
Looking to Safeguard Blood Supply, FDA Proposes Risk Assessment for Blood Donations
January 27th 2023
